Articles

Resolution of bone marrow fibrosis in a patient receiving JAK1/JAK2 inhibitor treatment with ruxolitinib

Guy’s and St. Thomas’ NHS Foundation Trust, London, UK
Guy’s and St. Thomas’ NHS Foundation Trust, London, UK
Guy’s and St. Thomas’ NHS Foundation Trust, London, UK
Guy’s and St. Thomas’ NHS Foundation Trust, London, UK
Guy’s and St. Thomas’ NHS Foundation Trust, London, UK
Guy’s and St. Thomas’ NHS Foundation Trust, London, UK
Vol. 98 No. 12 (2013): December, 2013 https://doi.org/10.3324/haematol.2013.095109